The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research

Invivoscribe, Inc.2,000 enrolled

Overview

Acquire residual human specimens and/or samples from patient samples which were sent for testing at LabPMM, LLC for Clinical Research

Residual specimen/sample collection study where peripheral blood (PB), bone marrow (BM), genomic (gDNA), and/or formalin-fixed paraffin-embedded tissue (FFPE) specimens/samples are obtained from patient samples sent to LabPMM, LLC for clinical testing. Samples may be used for Clinical Research at LabPMM, LLC or at partner institutions

Study Type

OBSERVATIONAL

Enrollment

2,000

Conditions

Hematologic Diseases

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Specimen/sample, peripheral blood (PB), bone marrow (BM), genomic DNA (gDNA) and/or formalin-fixed paraffin-embedded tissue (FFPE) from patients whose specimens/samples have been sent to LabPMM for clinical testing 2. Donor Age ≥ 18 years Exclusion Criteria: 1. Sample/specimen has been obtained from a third-party vendor with a Materials Transfer Agreement (MTA) on file with LabPMM 2. The specimens/samples have previously been enrolled in a clinical study

Locations (1)

LabPMM

San Diego, California, United States

RECRUITING

Outcomes

Primary Outcomes

Enrollment

N=2000

Time frame: 3 years

Central Contacts

Andrew Schut

CONTACT

+1 858.224.6600 aschut@invivoscribe.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.